Bristol Myers Squibb has sued the Biden administration over payment terms for hospitals in the 340B Drug Discount Program.

Opinion: Low pay, high pressure, a troubling political landscape — it’s all leading to medical students electing not to ...

The law is intended to crack down on Chinese biotech companies, but it may become more difficult to pass next year.

The Office for Civil Rights is not checking if health care providers who handle Americans’ sensitive data comply with health ...

Klitzman joins today’s First Opinion Podcast along with Molly O’Neil Frank, the staff palliative care chaplain at Memorial ...

Bhattacharya would be in charge of Trump's bold goals to reform the NIH, which spends billions to fund medical research.

The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...

President-elect Trump has nominated biotech investor Jim O’Neill for deputy secretary of the Health and Human Services ...

Health officials in British Columbia, Canada, have failed, for now, to confirm how a teenager there became infected with H5N1 ...

An Amgen obesity drug helped participants lose a substantial amount of weight, but questions about how competitive it could ...

I spent four crazy years writing about Cassava Sciences, Adam Feuerstein writes. Yesterday, the story ended exactly as many ...

Marty Makary, a Johns Hopkins surgeon and outspoken critic of parts of the U.S. medical system, is Trump’s pick for FDA ...